Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-ERK1/2 antibody (140-220 aa) [1H4] (STJ97783) | Login | Anti-ERK1/2 antibody (140-220 aa) [1H4] (STJ97783) | ||||||||||||||||
|
||||||||||||||||||
Anti-Acetyl-EPAS1-K385 antibody (STJ97799) | Login | Anti-Acetyl-EPAS1-K385 antibody (STJ97799) | ||||||||||||||||
|
||||||||||||||||||
Anti-Acetyl-E2F3-Lys168 antibody (130-200 aa) (STJ97801) | Login | Anti-Acetyl-E2F3-Lys168 antibody (130-200 aa) (STJ97801) | ||||||||||||||||
|
||||||||||||||||||
Anti-PWWP3A antibody (661-710 aa) (STJ98584) | Login | Anti-PWWP3A antibody (661-710 aa) (STJ98584) | ||||||||||||||||
|
||||||||||||||||||
Anti-APP antibody (221-270 aa) (STJ98585) | Login | Anti-APP antibody (221-270 aa) (STJ98585) | ||||||||||||||||
|
||||||||||||||||||
Anti-TSC1 antibody (360-440 aa) (STJ98591) | Login | Anti-TSC1 antibody (360-440 aa) (STJ98591) | ||||||||||||||||
|
||||||||||||||||||
Anti-APP antibody (631-680 aa) (STJ98604) | Login | Anti-APP antibody (631-680 aa) (STJ98604) | ||||||||||||||||
|
||||||||||||||||||
Anti-EDNRB antibody (31-80 aa) (STJ98617) | Login | Anti-EDNRB antibody (31-80 aa) (STJ98617) | ||||||||||||||||
|
||||||||||||||||||
Anti-PTHLH antibody (101-150 aa) (STJ98621) | Login | Anti-PTHLH antibody (101-150 aa) (STJ98621) | ||||||||||||||||
|
||||||||||||||||||
Anti-ACSS1 antibody (620-689 aa) (STJ98641) | Login | Anti-ACSS1 antibody (620-689 aa) (STJ98641) | ||||||||||||||||
|
||||||||||||||||||
Anti-SMARCB1 antibody (331-380 aa) (STJ98643) | Login | Anti-SMARCB1 antibody (331-380 aa) (STJ98643) | ||||||||||||||||
|
||||||||||||||||||
Anti-TCL1A antibody (30-110 aa) (STJ98671) | Login | Anti-TCL1A antibody (30-110 aa) (STJ98671) | ||||||||||||||||
|
||||||||||||||||||
Anti-CALCA antibody (80-141 aa) (STJ98672) | Login | Anti-CALCA antibody (80-141 aa) (STJ98672) | ||||||||||||||||
|
||||||||||||||||||
Anti-RPA3 antibody (30-80 aa) (STJ98675) | Login | Anti-RPA3 antibody (30-80 aa) (STJ98675) | ||||||||||||||||
|
||||||||||||||||||
Anti-Acetyl-FOXO4-Lys189 antibody (189 aa) (STJ98685) | Login | Anti-Acetyl-FOXO4-Lys189 antibody (189 aa) (STJ98685) | ||||||||||||||||
|
||||||||||||||||||
Anti-Mono-Methyl-Histone H4-Lys21 antibody (21 aa) (STJ98696) | Login | Anti-Mono-Methyl-Histone H4-Lys21 antibody (21 aa) (STJ98696) | ||||||||||||||||
|
||||||||||||||||||
Anti-ANXA1 antibody (130-180 aa) (STJ98699) | Login | Anti-ANXA1 antibody (130-180 aa) (STJ98699) | ||||||||||||||||
|
||||||||||||||||||
Anti-CCR5 antibody (151-200 aa) (STJ98700) | Login | Anti-CCR5 antibody (151-200 aa) (STJ98700) | ||||||||||||||||
|
||||||||||||||||||
Anti-FLT4 antibody (640-700 aa) (STJ98712) | Login | Anti-FLT4 antibody (640-700 aa) (STJ98712) | ||||||||||||||||
|
||||||||||||||||||
Anti-HAVCR1 antibody (40-100 aa) (STJ98725) | Login | Anti-HAVCR1 antibody (40-100 aa) (STJ98725) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDCD1LG2 antibody (31-80 aa) (STJ98748) | Login | Anti-PDCD1LG2 antibody (31-80 aa) (STJ98748) | ||||||||||||||||
|
||||||||||||||||||
Anti-IL12B antibody (241-290 aa) (STJ98797) | Login | Anti-IL12B antibody (241-290 aa) (STJ98797) | ||||||||||||||||
|
||||||||||||||||||
Anti-TG antibody (2511-2560 aa) (STJ98806) | Login | Anti-TG antibody (2511-2560 aa) (STJ98806) | ||||||||||||||||
|
||||||||||||||||||
Anti-NAPSA antibody (191-240 aa) (STJ98810) | Login | Anti-NAPSA antibody (191-240 aa) (STJ98810) | ||||||||||||||||
|
||||||||||||||||||
Anti-CCN2 antibody (141-190 aa) (STJ98812) | Login | Anti-CCN2 antibody (141-190 aa) (STJ98812) | ||||||||||||||||
|